Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis - Related Studies

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

This study has been completed.

Study NCT00116649. Last updated on November 19, 2008. Information provided by Graceway Pharmaceuticals, LLC

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Keratosis

2	More general conditions related to this trial
		Skin Diseases

3	Interventions listed in this trial
		imiquimod cream

4	Additional drug interventions recognized in this trial
		Imiquimod

5	More general drug interventions related to this trial
		Adjuvants, Immunologic
		Antineoplastic Agents
		Immunologic Factors
		Interferon Inducers
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Graceway Pharmaceuticals, LLC